IMMUNOLOGIC AND CLINICAL ASPECTS OF IMMUNE COMPLEX DISEASEINMAN RD; DAY NK.1981; AM. J. MED.; ISSN 0002-9343; USA; DA. 1981; VOL. 70; NO 5; PP. 1097-1106; BIBL. 103 REF.Article

THE PRESENCE OF ACTIVE C1(C1) ON PERIPHERAL HUMAN LYMPHOCYTESKITAMURA H; TESHIMA H; DAY NK et al.1978; VOX SANG.; CHE; DA. 1978; VOL. 35; NO 4; PP. 197-206; BIBL. 18 REF.Article

ERYTHEMA MULTIFORME: REPORT OF TWO CASES AND SPECULATION ON IMMUNE MECHANISMS INVOLVED IN THE PATHOGENESIS.SAFAI B; GOOD RA; DAY NK et al.1977; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1977; VOL. 7; NO 3; PP. 379-385; BIBL. 11 REF.Article

HYPOCOMPLEMENTEMIA ASSOCIATED WITH NATURALLY OCCURRING LYMPHOSARCOMA IN PET CATSKOBILINSKY L; HARDY WD JR; DAY NK et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 6; PP. 2139-2142; BIBL. 27 REF.Article

EFFECT OF COBRA VENOM FACTOR ON THE LOCAL GVH REACTION. I. PARTIAL CHARACTERIZATION OF A CYTOTOXIC FACTOR FROM COBRA VENOM FOR RAT LYMPHOCYTES = EFFET DU FACTEUR DU VENIN DE COBRA SUR LA REACTION LOCALE GVH. I. CARACTERISATION PARTIELLE D'UN FACTEUR CYTOTOXIQUE DU VENIN DE COBRA POUR LES LYMPHOCYTES DE RATBALLOW M; DAY NK; GOOD RA et al.1973; J. IMMUNOL.,; U.S.A.; DA. 1973; VOL. 110; NO 2; PP. 354-361; BIBL. 29REF.Serial Issue

MURINE FACTOR B: ELECTROPHORETIC POLYMORPHISM.RUBINSTEIN P; ROSENFIELD STEELE P; DAY NK et al.1977; IMMUNOGENETICS; GERM.; DA. 1977; VOL. 5; NO 4; PP. 363-366; BIBL. 15 REF.Article

DEMONSTRATION OF 11S IGA ANTIBODY TO SPERMATOZOA IN HUMAN SEMINAL FLUIDWITKIN SS; ZELIKOVSKY G; GOOD RA et al.1981; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1981; VOL. 44; NO 2; PP. 368-374; BIBL. 12 REF.Article

THE COMPLEMENT SYSTEM IN BULLOUS PEMPHIGOID. II. IMMUNOFLUORESCENT EVIDENCE FOR BOTH CLASSICAL AND ALTERNATE-PATHWAY ACTIVATIONJORDON RE; SCHROETER AL; GOOD RA et al.1975; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1975; VOL. 3; NO 3; PP. 307-314; BIBL. 21REF.Article

DIFFUSE NORMOLIPAEMIC PLANE XANTHOMATOSIS. AN ABNORMAL COMPLEMENT COMPONENT PROFILEJORDON RE; MCDUFFIE FC; GOOD RA et al.1974; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1974; VOL. 18; NO 3; PP. 407-415; BIBL. 1P.Article

ANTIBODIES REACTIVE WITH THE MOURE MAMMARY TUMOR VIRUS IN SERA OF BREAST CANCER PATIENTSWITKIN SS; SARKAR NH; KINNE DW et al.1980; INTERNATION. J. CANCER; CHE; DA. 1980; VOL. 25; NO 6; PP. 721-725; BIBL. 12 REF.Article

CIRCULATING IMMUNE COMPLEXES IN SERA OF CHILDREN WITH NEUROBLASTOMA: CORRELATION WITH STAGE OF DISEASEBRANDEIS WE; HELSON L; WANG Y et al.1978; J. CLIN. INVEST.; USA; DA. 1978; VOL. 62; NO 6; PP. 1201-1209; BIBL. 56 REF.Article

LUPUS ERYTHEMATOSUS-LIKE SYNDROME WITH A FAMILIAL DEFICIENCY OF C2DOUGLASS MC; LAMBERG SI; LORINCZ AL et al.1976; ARCH. DERMATOL.; U.S.A.; DA. 1976; VOL. 112; NO 5; PP. 671-674; BIBL. 28 REF.Article

REVERSIBLE ACTIVATION OF PRIACTIVATOR (FACTOR B) OF THE ALTERNATIVE PATHWAY WITHOUT CLEAVAGE OF THE MOLECULE.DAY NK; SCHREIBER RD; GOTZE O et al.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 6-7; PP. 715-720; BIBL. 16 REF.Article

DEMONSTRATION OF IGG F_C RECEPTORS ON SPERMATOZOA AND THEIR UTILIZATION FOR THE DETECTION OF CIRCULATING IMMUNE COMPLEXES IN HUMAN SERUMWITKIN SS; SHAHANI SK; GUPTA S et al.1980; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1980; VOL. 41; NO 3; PP. 441-452; BIBL. 37 REF.Article

DEVELOPMENTAL ASPECTS OF COMPLEMENT COMPONENTS IN THE NEWBORN. THE PRESENCE OF COMPLEMENT COMPONENTS AND C3 PROACTIVATOR (PROPERDIN FACTOR B) IN HUMAN COLOSTRUMBALLOW M; FANG F; GOOD RA et al.1974; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1974; VOL. 18; NO 2; PP. 257-266; BIBL. 1P.Article

IGA ANTIBODY TO SPERMATOZOA IN SEMINAL AND PROSTATIC FLUIDS OF A SUBFERTILE MANWITKIN SS; ZELIKOVSKY G; BONGIOVANNI AM et al.1982; JAMA, J. AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1982; VOL. 247; NO 7; PP. 1014-1015; BIBL. 9 REF.Article

CIRCULATING IMMUNE COMPLEXES, COMPLEMENT AND COMPLEMENT COMPONENT LEVELS IN CHILDHOOD HODGKIN'S DISEASEBRANDEIS WE; TAN C; WANG Y et al.1980; CLIN. EXPER. IMMUNOL.; GBR; DA. 1980; VOL. 39; NO 3; PP. 551-561; BIBL. 31 REF.Article

INHIBITION OF EFFECTOR CELL FUNCTIONS IN NATURAL KILLER CELL ACTIVITY (NK) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN MICE BY NORMAL AND CANCER SERANAIR PNM; FERNANDES G; ONOE K et al.1980; INTERNATION. J. CANCER; CHE; DA. 1980; VOL. 25; NO 5; PP. 667-677; BIBL. 2 P.Article

SPERM IMMOBILIZATION BY SERA FROM UNIMMUNIZED GUINEA PIGS: REQUIREMENTS FOR IMMUNOGLOBULIN AND COMPLEMENTWITKIN SS; BROWN CA; GOOD RA et al.1980; J. REPROD. IMMUNOL.; NLD; DA. 1980; VOL. 2; NO 2; PP. 65-72; BIBL. 19 REF.Article

VIROLYSIS OF MOUSE MAMMARY TUMOR VIRUS BY SERA FROM BREAST CANCER PATIENTSWITKIN SS; EGELI RA; SARKAR NH et al.1979; PROC. NATION. ACAD. SCI. U.S.A.; USA; DA. 1979; VOL. 76; NO 6; PP. 2984-2987; BIBL. 17 REF.Article

CIRCULATING IMMUNE COMPLEXES DETECTED BY ¹²⁵I-C1Q DEVIATION TEST IN SERA OF CANCER PATIENTS.TESHIMA H; WANEBO H; PINSKY C et al.1977; J. CLIN. INVEST.; U.S.A.; DA. 1977; VOL. 59; NO 6; PP. 1134-1142; BIBL. 28 REF.Article

COMPLEMENT INHIBITOR (S) RELEASED BY LEUKOCYTES. I. PRETREATMENT OS SHEEP ERYTHROCYTES WITH SUPERNATANTS OF MOUSE SPLEEN AND THYMUS CELLS INHIBIT WHOLE COMPLEMENT ACTIVITY AND C2 UTILIZATION.BERNARD A; BOUMSELL L; BORSOS T et al.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 115; NO 4; PP. 1087-1090; BIBL. 9 REF.Article

QUANTITATION OF CIRCULATING IMMUNE COMPLEXES IN SERUM BY RAJI CELLS USING AN ENZYME-LINKED IMMUNOSORBENT ASSAYCUNNINGHAM RUNDLES C; BRANDEIS WE; ZACHARCZUK T et al.1980; CLIN. EXPER. IMMUNOL.; GBR; DA. 1980; VOL. 40; NO 2; PP. 411-415; BIBL. 11 REF.Article

CIRCULATING IMMUNE COMPLEXES IN SERA OF DOGS WITH BENIGN AND MALIGNANT BREAST DISEASEGORDON BR; MOROFF S; HURVITZ AI et al.1980; CANCER RES.; ISSN 0008-5472; USA; DA. 1980; VOL. 40; NO 10; PP. 3627-3631; BIBL. 22 REF.Article

FORSSMAN-LIKE ANTIBODY LEVELS IN SERA OF PATIENTS WITH LUNG CANCERKITAMURA H; LEVINE P; PO JUN CHENG et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 8; PP. 2909-2913; BIBL. 15 REF.Article